Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliroden Long-Term Safety Extension in Alzheimer's
NCT00285077Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of paliroden in Alzheimer's disease (AD), sponsored by Sanofi. Started Mar 2004; status: completed.
02
Drugs
paliroden
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00285077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285077.